BICLUSTER_ID : UPREG-270
PATHOGENS /2/ : yersinia enterocolitica,porphyromonas gingivalis
TARGETS /14/ : IL12B, CCL2, THBD, LPL, SERPINB2, BMP2, IL3RA, IL6, PTGS2, F3, CYSLTR2, PIM1, CD86, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 4 PATHWAY UPCCL22, PCDH7, CCL2, CH25H, ARID5B, SOCS3, INHBA, RIPK2, CD86, EGR2, TNC, REL, ST8SIA1, IBRDC3, KCNK3, KLF4, CITED2, BMP2, IL10, IL6, F3, TCF7, CSPG2
NETPATH IL 4 PATHWAY DOWNIL6, GADD45B, PTGS2, CHST2, CYSLTR2, CCL2, LPL
NETPATH IL 3 PATHWAY UPIL3RA, SOCS3, CCL7, CCL2, CD86, PIM1
NCI IL23PATHWAYSOCS3, IL6, IL12B, CXCL1, CCL2, CXCL9, IL18R1
NETPATH EGFR1 PATHWAY UPEMP1, TAGLN, ATP9B, PLK2, VCL, SERPINB2, HAS2, PTHLH, CXCL5, PTGS2, TNFAIP3, FGFBP1, CTGF, DUSP1, PLAUR
NETPATH IL 9 PATHWAY UPSOCS3, CCL7, CCL2, PIM1, CITED2, IL5RA
NCI IL27PATHWAYIL12B, IL6
NETPATH IL 7 PATHWAY UPCCL22, CXCL5, CXCL1, CD86
NETPATH HEDGEHOG PATHWAY UPIGF2, ANGPT2, GLI1, THBD, MYC
NCI ATF2 PATHWAYSOCS3, ATF3, IL6, DUSP10, DUSP1
NETPATH IL 6 PATHWAY UPSOCS3, GADD45B, CXCL1, ZFP36, CITED2, PIM1
VERHAAK AML WITH NPM1 MUTATED DN
ODONNELL METASTASIS UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
LINDGREN BLADDER CANCER CLUSTER 2B
VANHARANTA UTERINE FIBROID DN
KEGG GRAFT VERSUS HOST DISEASE
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
ST P38 MAPK PATHWAYDUSP10, DUSP1
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
ODONNELL TFRC TARGETS UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
VECCHI GASTRIC CANCER EARLY DN
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
SMID BREAST CANCER LUMINAL A UP
LIN SILENCED BY TUMOR MICROENVIRONMENT
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
SABATES COLORECTAL ADENOMA DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
AGARWAL AKT PATHWAY TARGETS
HINATA NFKB TARGETS KERATINOCYTE UP
GENTILE UV HIGH DOSE UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR UP
OSADA ASCL1 TARGETS DN
VART KSHV INFECTION ANGIOGENIC MARKERS UP
AMIT SERUM RESPONSE 60 MCF10A
DAVICIONI PAX FOXO1 SIGNATURE IN ARMS DN
DIRMEIER LMP1 RESPONSE EARLY
MCBRYAN PUBERTAL BREAST 3 4WK UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
CERVERA SDHB TARGETS 1 UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
LIAN LIPA TARGETS 6M
WINTER HYPOXIA METAGENE
MCLACHLAN DENTAL CARIES UP
DAZARD RESPONSE TO UV NHEK UP
GAJATE RESPONSE TO TRABECTEDIN UP
TAVOR CEBPA TARGETS UP
YAUCH HEDGEHOG SIGNALING PARACRINE DN
HADDAD T LYMPHOCYTE AND NK PROGENITOR DN
SMID BREAST CANCER LUMINAL B DN
NCI AMB2 NEUTROPHILS PATHWAY
BOQUEST STEM CELL CULTURED VS FRESH DN
GESERICK TERT TARGETS DN
FURUKAWA DUSP6 TARGETS PCI35 UP
AMIT SERUM RESPONSE 120 MCF10A
CLASPER LYMPHATIC VESSELS DURING METASTASIS UP
LEE LIVER CANCER CIPROFIBRATE UP
HALMOS CEBPA TARGETS DN
ZIRN TRETINOIN RESPONSE UP
SESTO RESPONSE TO UV C3
AMIT EGF RESPONSE 40 MCF10A
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME G ALPHA I SIGNALLING EVENTS
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
RICKMAN HEAD AND NECK CANCER F
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
SU KIDNEY
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 DN
REACTOME GPCR LIGAND BINDING
TIAN TNF SIGNALING VIA NFKB
BENPORATH SUZ12 TARGETS
LIU CDX2 TARGETS UP
REACTOME NCAM1 INTERACTIONS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
HINATA NFKB TARGETS FIBROBLAST UP
AMIT EGF RESPONSE 60 MCF10A
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
NIKOLSKY BREAST CANCER 7P15 AMPLICON
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
KONDO PROSTATE CANCER WITH H3K27ME3
NCI EXTRINSIC PATHWAY
KEGG ASTHMA
REACTOME DOWNSTREAM EVENTS IN GPCR SIGNALING
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
HALMOS CEBPA TARGETS UP
LEE LIVER CANCER DENA UP
WALLACE PROSTATE CANCER RACE UP
CHANDRAN METASTASIS DN
NETPATH IL 7 PATHWAY
BENPORATH ES WITH H3K27ME3
SHIPP DLBCL VS FOLLICULAR LYMPHOMA DN
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
VERNELL RETINOBLASTOMA PATHWAY DN
MAHADEVAN RESPONSE TO MP470 DN
TSAI RESPONSE TO RADIATION THERAPY
RIGGI EWING SARCOMA PROGENITOR UP
BUDHU LIVER CANCER METASTASIS DN
KEGG JAK STAT SIGNALING PATHWAY
HARRIS HYPOXIA
BIOCARTA CYTOKINE PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
SOUCEK MYC TARGETS
NAGASHIMA NRG1 SIGNALING UP
BIOCARTA IL5 PATHWAY
BIOCARTA DC PATHWAY
ZERBINI RESPONSE TO SULINDAC UP
BOYLAN MULTIPLE MYELOMA C D DN
BENPORATH PRC2 TARGETS
BILBAN B CLL LPL DN
FRASOR RESPONSE TO ESTRADIOL DN
WU HBX TARGETS 2 DN
NCI PROSTANOID HORMONES
RASHI RESPONSE TO IONIZING RADIATION 1
MAHADEVAN RESPONSE TO MP470 UP
CORRE MULTIPLE MYELOMA UP
SMID BREAST CANCER NORMAL LIKE UP
CADWELL ATG16L1 TARGETS UP
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
NETPATH WNT PATHWAY DOWNT, CXCL1, TNFRSF4, WISP1
DAUER STAT3 TARGETS UP
WU HBX TARGETS 1 UP
AMIT EGF RESPONSE 60 HELA
BERENJENO TRANSFORMED BY RHOA FOREVER DN
DAZARD UV RESPONSE CLUSTER G2
MCLACHLAN DENTAL CARIES DN
SEKI INFLAMMATORY RESPONSE LPS UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIERIE INFLAMMATORY RESPONSE TGFB1
RICKMAN HEAD AND NECK CANCER C
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
ONDER CDH1 TARGETS 2 DN
LIU TARGETS OF VMYB VS CMYB DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KEGG HEMATOPOIETIC CELL LINEAGE
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
BROWNE HCMV INFECTION 1HR UP
KIM MYCL1 AMPLIFICATION TARGETS UP
IIZUKA RECURRENT LIVER CANCER
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BENPORATH EED TARGETS
GOUYER TATI TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
RICKMAN HEAD AND NECK CANCER E
LU IL4 SIGNALING
WATTEL AUTONOMOUS THYROID ADENOMA DN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAMASHITA METHYLATED IN PROSTATE CANCER
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica p60 bl6porphyromonas gingivalisGeneSet Name
0.00010 0.03326NETPATH_IL_4_PATHWAY_UP
0.00146 0.00395NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.12641NETPATH_IL_3_PATHWAY_UP
0.00000 0.00584NCI_IL23PATHWAY
0.00038 0.08355NETPATH_EGFR1_PATHWAY_UP
0.00016 0.01126NETPATH_IL_9_PATHWAY_UP
0.02901 0.07257NCI_IL27PATHWAY
0.00709 0.01741NETPATH_IL_7_PATHWAY_UP
0.07807 0.18257NETPATH_HEDGEHOG_PATHWAY_UP
0.05363 0.00897NCI_ATF2_PATHWAY
0.00000 0.09273NETPATH_IL_6_PATHWAY_UP
0.12021 0.12683VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.14922 0.03896ODONNELL_METASTASIS_UP
0.00021 0.02363GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01562 0.12757LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.03690 0.15414VANHARANTA_UTERINE_FIBROID_DN
0.00069 0.15597KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00794 0.00871REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00054 0.09297REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.04591 0.02335LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.02204 0.08020ST_P38_MAPK_PATHWAY
0.00297 0.02386RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00029 0.00457LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.04740 0.06632ODONNELL_TFRC_TARGETS_UP
0.03636 0.02357GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.02482 0.01217VECCHI_GASTRIC_CANCER_EARLY_DN
0.00563 0.04059IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00021 0.00131AMIT_EGF_RESPONSE_40_HELA
0.04240 0.12658SMID_BREAST_CANCER_LUMINAL_A_UP
0.05264 0.00830LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.00708 0.12409TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00226 0.01473SABATES_COLORECTAL_ADENOMA_DN
0.01867 0.07753TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.12093 0.03820BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.07827 0.13789AGARWAL_AKT_PATHWAY_TARGETS
0.00000 0.00133HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.04436 0.06659GENTILE_UV_HIGH_DOSE_UP
0.03296 0.15449TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.08169 0.00441OSADA_ASCL1_TARGETS_DN
0.00294 0.19275VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00000 0.00000AMIT_SERUM_RESPONSE_60_MCF10A
0.00178 0.06592DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.00018 0.00483DIRMEIER_LMP1_RESPONSE_EARLY
0.02287 0.15466MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.13918 0.07224KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00872 0.05514MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.15332 0.11865CERVERA_SDHB_TARGETS_1_UP
0.00000 0.12784ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00026 0.00916ONDER_CDH1_TARGETS_3_DN
0.17962 0.04327DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00177 0.09798LIAN_LIPA_TARGETS_6M
0.01519 0.16096WINTER_HYPOXIA_METAGENE
0.00050 0.08054MCLACHLAN_DENTAL_CARIES_UP
0.01128 0.10008DAZARD_RESPONSE_TO_UV_NHEK_UP
0.02695 0.03047GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.06979 0.02033TAVOR_CEBPA_TARGETS_UP
0.13132 0.03059YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN
0.05879 0.04407HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.00018 0.04544SMID_BREAST_CANCER_LUMINAL_B_DN
0.17478 0.08425NCI_AMB2_NEUTROPHILS_PATHWAY
0.09376 0.09904BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00000 0.03305GESERICK_TERT_TARGETS_DN
0.16226 0.18949FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.00007 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.11573 0.00124CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.09770 0.14488LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.17655 0.09878HALMOS_CEBPA_TARGETS_DN
0.13455 0.04036ZIRN_TRETINOIN_RESPONSE_UP
0.00078 0.00266SESTO_RESPONSE_TO_UV_C3
0.05158 0.07280AMIT_EGF_RESPONSE_40_MCF10A
0.04624 0.14398BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.01582 0.15518REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.00109 0.12681GEISS_RESPONSE_TO_DSRNA_UP
0.00272 0.01492GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00357 0.19120RICKMAN_HEAD_AND_NECK_CANCER_F
0.00240 0.12675BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.06464 0.12574SU_KIDNEY
0.17309 0.15502SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN
0.01873 0.02865REACTOME_GPCR_LIGAND_BINDING
0.00016 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.09098 0.00963BENPORATH_SUZ12_TARGETS
0.12901 0.03346LIU_CDX2_TARGETS_UP
0.00706 0.05522REACTOME_NCAM1_INTERACTIONS
0.00058 0.11913LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00025NAGASHIMA_EGF_SIGNALING_UP
0.06744 0.05191AMIT_DELAYED_EARLY_GENES
0.00034 0.03916HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00000 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00005 0.09026CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00000 0.00839KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00037 0.11857NOJIMA_SFRP2_TARGETS_UP
0.06771 0.09393NIKOLSKY_BREAST_CANCER_7P15_AMPLICON
0.00000 0.03623OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.12852 0.06603KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.19235 0.06423NCI_EXTRINSIC_PATHWAY
0.02752 0.03097KEGG_ASTHMA
0.15136 0.06035REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING
0.00258 0.00222BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.01657 0.19004CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.00022 0.03979HALMOS_CEBPA_TARGETS_UP
0.18788 0.03890LEE_LIVER_CANCER_DENA_UP
0.00029 0.19031WALLACE_PROSTATE_CANCER_RACE_UP
0.12846 0.10959CHANDRAN_METASTASIS_DN
0.17603 0.08902NETPATH_IL_7_PATHWAY
0.05473 0.00561BENPORATH_ES_WITH_H3K27ME3
0.19676 0.16301SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.03385 0.04210GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.07021 0.19271VERNELL_RETINOBLASTOMA_PATHWAY_DN
0.00072 0.01107MAHADEVAN_RESPONSE_TO_MP470_DN
0.01450 0.09812TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00782 0.12440RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.02833 0.10290BUDHU_LIVER_CANCER_METASTASIS_DN
0.00111 0.12580KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00029 0.08079HARRIS_HYPOXIA
0.00009 0.00278BIOCARTA_CYTOKINE_PATHWAY
0.00040 0.03845TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.00018 0.03916SOUCEK_MYC_TARGETS
0.00000 0.00124NAGASHIMA_NRG1_SIGNALING_UP
0.01559 0.01916BIOCARTA_IL5_PATHWAY
0.04231 0.00361BIOCARTA_DC_PATHWAY
0.05840 0.02341ZERBINI_RESPONSE_TO_SULINDAC_UP
0.01871 0.19005BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.04490 0.00324BENPORATH_PRC2_TARGETS
0.00270 0.09608BILBAN_B_CLL_LPL_DN
0.02087 0.01471FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.16824 0.09838WU_HBX_TARGETS_2_DN
0.19314 0.10138NCI_PROSTANOID_HORMONES
0.12899 0.19001RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.00018 0.18333MAHADEVAN_RESPONSE_TO_MP470_UP
0.03661 0.00014CORRE_MULTIPLE_MYELOMA_UP
0.01677 0.12023SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.04238 0.00064CADWELL_ATG16L1_TARGETS_UP
0.00394 0.00825SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.05832 0.19409NETPATH_WNT_PATHWAY_DOWN
0.06189 0.00811DAUER_STAT3_TARGETS_UP
0.00917 0.11831WU_HBX_TARGETS_1_UP
0.00019 0.11163AMIT_EGF_RESPONSE_60_HELA
0.00332 0.06745BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.01250 0.01540DAZARD_UV_RESPONSE_CLUSTER_G2
0.00065 0.08235MCLACHLAN_DENTAL_CARIES_DN
0.00000 0.00125SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.00127ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.05248 0.06702BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00602 0.16035RICKMAN_HEAD_AND_NECK_CANCER_C
0.10800 0.01154TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.00022 0.07092ONDER_CDH1_TARGETS_2_DN
0.04786 0.00258LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00030 0.05737HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00043 0.02431KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00490 0.00823BROWNE_HCMV_INFECTION_1HR_UP
0.10098 0.03761KIM_MYCL1_AMPLIFICATION_TARGETS_UP
0.09789 0.03888IIZUKA_RECURRENT_LIVER_CANCER
0.00037 0.09753GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.10334 0.03108BENPORATH_EED_TARGETS
0.08058 0.08157GOUYER_TATI_TARGETS_UP
0.00000 0.03617OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.03215 0.12632RICKMAN_HEAD_AND_NECK_CANCER_E
0.00176 0.06609LU_IL4_SIGNALING
0.01530 0.00215WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.00000 0.10670PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.00195 0.15721YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.14239 0.15853YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1